GAMA
PFE icon

Graticule Asia Macro Advisors’s Pfizer PFE Stock Holding History

Graticule Asia Macro Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
+5,561
New +$145K 0.01% 71
2017
Q2 		– Sell
-61,132
Closed -$1.98M – 144
2017
Q1 		$1.98M Buy
+61,132
New +$1.93M 0.12% 100

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Graticule Asia Macro Advisors's PFE Position: Q2 2026 in Review

Graticule Asia Macro Advisors opened a new position in Pfizer (PFE) in Q2 2026: 5,561 shares worth $134K. The stake represents 0.01% of the portfolio and ranks #71 among its holdings. This is a return to the name: Graticule Asia Macro Advisors previously reported a position in PFE as recently as Q1 2017.

Graticule Asia Macro Advisors first reported a position in PFE in Q1 2017 and has held it in 2 quarters since. The position peaked at $1.98M in Q1 2017. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Graticule Asia Macro Advisors held 5,561 shares of Pfizer worth $134K as of Q2 2026.
  • Pfizer was a new Graticule Asia Macro Advisors position in Q2 2026.
  • Pfizer made up 0.01% of Graticule Asia Macro Advisors's portfolio in Q2 2026, its #71 holding.
  • Graticule Asia Macro Advisors first reported a position in Pfizer in Q1 2017 and has held it in 2 quarters since.
  • Graticule Asia Macro Advisors's Pfizer position peaked at $1.98M in Q1 2017.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.